Sign Up Today and Learn More About TYK Medicines Stock
Invest in or calculate the value of your shares in TYK Medicines or other pre-IPO companies through EquityZen's platform.
TYK Medicines Stock (TYME)
TYK Medicines is a drug research and development company.
About TYK Medicines Stock
Founded
2018
Industries
Software, Artificial Intelligence, Data and Analytics
TYK Medicines Press Mentions
Stay in the know about the latest news on TYK Medicines
TYK Medicines raises $74M in HKEX IPO to launch EGFR inhibitor
bioworld • Aug 29, 2024
TYK Medicines Stages $74 Million Hong Kong IPO
chinabiotoday • Aug 17, 2024
TYK Medicines reports new compounds for preventing and/or treating neurodegenerative disease
bioworld • Aug 03, 2024
TYK Medicines and Zhejiang Tongyuankang Pharmaceutical discover new PTPN11 inhibitors
bioworld • Jan 31, 2023
TYK Medicines Management
Leadership team at TYK Medicines
Chairman, CEO and Founder
Wu Yusheng
Director and Chief Scientific Officer
Li Jun
Join now and verify your accreditation status to gain access to:
- TYK Medicines current valuation
- TYK Medicines stock price
- Available deals in TYK Medicines and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in TYK Medicines stock?
Accredited investors can buy pre-IPO stock in companies like TYK Medicines through EquityZen funds. These investments are made available by existing TYK Medicines shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell TYK Medicines stock?
Shareholders can sell their TYK Medicines stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
